L, S., M, B., G, S., B, S., E, R., S, C., . . . S, S. (2026). SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis. JACC. Advances, 5(6 Pt 2), 102790. https://doi.org/10.1016/j.jacadv.2026.102790
Chicago Style (17th ed.) CitationL, Spadafora, et al. "SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis." JACC. Advances 5, no. 6 Pt 2 (2026): 102790. https://doi.org/10.1016/j.jacadv.2026.102790.
MLA (9th ed.) CitationL, Spadafora, et al. "SGLT2 Inhibitors in Cardio-Oncology: A Systematic Review and Meta-Analysis." JACC. Advances, vol. 5, no. 6 Pt 2, 2026, p. 102790, https://doi.org/10.1016/j.jacadv.2026.102790.
Warning: These citations may not always be 100% accurate.